CAWM
GSK icon

Capital A Wealth Management’s GSK GSK Stock Holding History

Capital A Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-724
Closed -$28K – 613
2025
Q1 		$28K Hold
724
– – 0.03% 196
2024
Q4 		$24.5K Buy
+724
New +$26.1K 0.04% 216

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Capital A Wealth Management's GSK Position: Q2 2025 in Review

Capital A Wealth Management sold out of GSK (GSK) in Q2 2025, closing a stake of 724 shares — an estimated $28K sold.

Capital A Wealth Management first reported a position in GSK in Q4 2024 and held it in 2 quarters. The position peaked at $28K in Q1 2025. 891 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

  • Capital A Wealth Management reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
  • Capital A Wealth Management sold 724 GSK shares in Q2 2025, an estimated $28K.
  • Capital A Wealth Management first reported a position in GSK in Q4 2024 and held it in 2 quarters.
  • Capital A Wealth Management's GSK position peaked at $28K in Q1 2025.
  • 891 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Capital A Wealth Management's 13F filing for Q2 2025, filed 26 Sep 2025.